Ads
related to: when is brachytherapy not recommended for prostate cancer- Patient Story Videos
Watch Real Stories Of Patients
Who Have Battled Prostate Cancer.
- Support Your Loved Ones
Explore Resources And Get Guidance
On How To Care For Someone With PC.
- Cancer Progression
Understand The Different Kinds Of
Prostate Cancer & Its Progression.
- Learn About Advanced PC
Understand The Symptoms, Diagnosis
And Find Helpful Resources.
- Patient Story Videos
Search results
Results from the WOW.Com Content Network
LDR prostate brachytherapy (seed or polymer source implantation) is recommended as a treatment for patients whose cancer is at an early stage (cancer stages T1 to T2), and which has not spread beyond the prostate (localised disease).
Treatment for prostate cancer may involve active surveillance, surgery, radiation therapy – including brachytherapy (prostate brachytherapy) and external-beam radiation therapy, proton therapy, high-intensity focused ultrasound (HIFU), cryosurgery, hormonal therapy, chemotherapy, or some combination. Treatments also extend to survivorship ...
Body sites in which brachytherapy can be used to treat cancer. Brachytherapy is commonly used to treat cancers of the cervix, prostate, breast, and skin. [1]Brachytherapy can also be used in the treatment of tumours of the brain, eye, head and neck region (lip, floor of mouth, tongue, nasopharynx and oropharynx), [10] respiratory tract (trachea and bronchi), digestive tract (oesophagus, gall ...
According to a new study, active monitoring of the disease has the same high survival rates after 15 years as radiotherapy or surgery.
Because of this, prostate cancer screenings are not recommended for men age 70 and older, or men who have less than a 10-year life expectancy. ... A family history of not only prostate cancer, but ...
Prostate cancer antigen 3 is a urine test that detects the overexpression of the PCA3 gene, an indicator of prostate cancer. [32] [46] [47] [44] ConfirmMDx is performed on tissue taken during a prostate biopsy. The test identifies men with clinically significant prostate cancer who would benefit from further testing and treatment.
Ads
related to: when is brachytherapy not recommended for prostate cancer